Skip to content

AMBIT BIOSCIENCES CORP

Delisted

CIK 1131543fmd_1RY7BW2R80XN0ZNV5YVPHVWYF1Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Jun 30, 2014, 10 periods

Latest annual · FY2013

Millions
Operating income
(7)
Net income
(11)
Free cash flow
(28)

Latest quarter · Q2 FY2014

Millions
Operating income
(11)
Net income
(8)
Free cash flow
(9)
Open Financials

AMBIT BIOSCIENCES CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Operating income-$7 million-$23.2 million10-K 2014-03-20 · proof
Net income-$11.2 million-$26.6 million10-K 2014-03-20 · proof
Cash from operating activities-$27.3 million-$28.8 million10-K 2014-03-20 · proof
Free cash flow-$27.9 million-$28.7 million10-K 2014-03-20 · proof
Total assets$73.9 million$20 million+269.9%10-K 2014-03-20 · proof
Total liabilities$16.4 million$214.9 million-92.4%10-K 2014-03-20 · proof
Cash and cash equivalents$71.2 million$17.5 million+307.2%10-K 2014-03-20 · proof
What was AMBIT BIOSCIENCES CORP's operating income in fiscal 2013?
AMBIT BIOSCIENCES CORP reported operating income of -$7 million for fiscal 2013 (the year ended Dec 31, 2013), against -$23.2 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What was AMBIT BIOSCIENCES CORP's net income in fiscal 2013?
AMBIT BIOSCIENCES CORP reported net income of -$11.2 million for fiscal 2013 (the year ended Dec 31, 2013), against -$26.6 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What was AMBIT BIOSCIENCES CORP's cash from operating activities in fiscal 2013?
AMBIT BIOSCIENCES CORP reported cash from operating activities of -$27.3 million for fiscal 2013 (the year ended Dec 31, 2013), against -$28.8 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What was AMBIT BIOSCIENCES CORP's free cash flow in fiscal 2013?
AMBIT BIOSCIENCES CORP reported free cash flow of -$27.9 million for fiscal 2013 (the year ended Dec 31, 2013), against -$28.7 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What are AMBIT BIOSCIENCES CORP's total assets?
As of Dec 31, 2013, AMBIT BIOSCIENCES CORP reported total assets of $73.9 million, against $20 million a year earlier (+269.9%). Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What are AMBIT BIOSCIENCES CORP's total liabilities?
As of Dec 31, 2013, AMBIT BIOSCIENCES CORP reported total liabilities of $16.4 million, against $214.9 million a year earlier (-92.4%). Source: the 10-K filed with the SEC on Mar 20, 2014. SEC
What are AMBIT BIOSCIENCES CORP's cash and cash equivalents?
As of Dec 31, 2013, AMBIT BIOSCIENCES CORP reported cash and cash equivalents of $71.2 million, against $17.5 million a year earlier (+307.2%). Source: the 10-K filed with the SEC on Mar 20, 2014. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1131543&period_type=annual&limit=5"

Information only, not investment advice.